CIK 0000744218 · Large accelerated filer
Celldex Therapeutics, Inc.
Sign in to watch- Ticker
- CLDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133191702
- Phone
- 908-200-7500
- Business address
- 53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
- Former names
- AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
- 8-K Event Other events
- 8-K Event Material agreement · Unregistered share sale
- 8-K/A Event Acquisition or sale completed
- 8-K Event Executive or director change
- 8-K Event Material agreement · Unregistered share sale · Other events
- 8-K Event Acquisition or sale completed · Delisting notice · Shareholder rights changed · Change in control · Executive or director change · Other events
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Results of operations
- 8-K Event Executive or director change
- S-4/A Deal Registration Statement - Business Combination
- S-4/A Deal Registration Statement - Business Combination
- 8-K Event Executive or director change
- S-4/A Deal Registration Statement - Business Combination
- 8-K Event Delisting notice
- S-4 Deal Registration Statement - Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Executive or director change
- 8-K Event Other events
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
Page 10 of 13 · 260 filings